Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Two phase III studies show efficacy of asenapine in treating mania in bipolar I disorder

Oct. 25, 2007

LX-1031 well tolerated in early studies in humans

Oct. 24, 2007

RGH-188 pharmacokinetics, dopamine receptor occupancy studied in volunteers

Oct. 24, 2007

Aripiprazole effective as acute and maintenance therapy for bipolar disorder

Oct. 24, 2007

Analysis reveals safe metabolic profile of bifeprunox

Oct. 24, 2007

Phase I clinical study of DC/Apo-Nec melanoma vaccine

Oct. 23, 2007

Targin improves opioid-induced bowel dysfunction in patients with chronic pain

Oct. 22, 2007

Efficacy, tolerability of tapentadol immediate release assessed in acute pain following bunionectomy

Oct. 19, 2007

Study suggests feasibility of vaccine prevention of maternal CMV infection

Oct. 18, 2007

Preclinical data on two novel PPAR modulators from Pierre Fabre

Oct. 18, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...